Why is breast cancer survival so much lower in low-income countries?
UK five-year breast cancer survival is almost 90% where organised screening exists. In many low-income settings it falls toward around 40% because cancers are found later. WHO counted 2.4 million new cases and 694,000 deaths in 2024. The gap is access, not biology. We fund screening abroad — not laboratory research.
Stage explains most of the cliff. Cancer Research UK reports almost 100% five-year survival at stage 1 in England and more than 30% at stage 4 (women diagnosed 2018–2022, England). Those numbers describe a high-income pathway. They are not a promise we can paste onto every district hospital. They show why finding cancer earlier matters. Read stages and UK survival.
We do not invent a “200 million women without screening” statistic. Hundreds of millions of women live without an organised national invitation programme. That is the access fact. Precise headcounts belong to WHO and national ministries, not to our donate form.
Does high incidence mean a country is worse at treating breast cancer?
No. High-income countries often record higher incidence because screening finds more cancers and people live longer. They also have the best survival. Lower recorded incidence can sit beside worse survival when most cancers are found late.
around 56,800 new breast cancer cases in females in the UK each year (Cancer Research UK). That burden is large — and UK five-year survival is still almost 90% because treatment and screening exist.
How many people die from breast cancer worldwide?
WHO reported 694,000 deaths and 2.4 million new diagnoses in 2024. Most deaths occur in low- and middle-income countries. We will not quote “90% of deaths” without a figure we can source on this page.
If you want the fundraising ask attached to that gap, use the developing-world crisis appeal or donate. This page stays an explainer so AI overviews and journalists are not fed inflated percentages.
What is Breast Cancer Charity doing about the gap?
We fund screening, education and treatment access through local partners — not laboratory trials. £25 funds one complete breast cancer screening. We do not publish live “women screened” counters until partner reports exist. See your impact.
Wrong door: if you need a person in the UK today, start at Breast Cancer Support.